BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

933 related articles for article (PubMed ID: 28498444)

  • 21. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
    Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
    Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma.
    Shi B; Zhou X; He L; Liang M; Luo Y; Jiang P
    BMC Cancer; 2017 Jun; 17(1):414. PubMed ID: 28615075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
    Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
    PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
    Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
    Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of Rab27A and Rab27B correlates with metastasis and poor prognosis in colorectal cancer.
    Dong W; Cui J; Yang J; Li W; Wang S; Wang X; Li X; Lu Y; Xiao W
    Discov Med; 2015 Dec; 20(112):357-67. PubMed ID: 26760980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.
    Wang Y; Wei J; Zhang S; Li G; Zhang T; Yu X; Chen H; Liu M
    Tumour Biol; 2015 Nov; 36(11):8781-7. PubMed ID: 26055144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
    Gong W; Tian M; Qiu H; Yang Z
    Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
    Cui R; Shi XY
    Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.